About Marc Litzenberg
Marc Litzenberg is a director at NeuroFine.
Form D filings also name Marc Litzenberg as a chief executive officer and director at Deinde Medical and an executive officer and director at Prometheus Therapeutics.
Marc Litzenberg first appears on SEC filings in 2019.
Experience
This experience comes from Marc Litzenberg's profile and from SEC filings. For roles taken from filings, the years are when the filings name Marc Litzenberg in the role, so the role may have started earlier or lasted longer.
EC
EOSolutions Corp Current
CEO
2017 – Present
Prometheus Therapeutics Inc.
Executive officer and director
2020 – 2024 · Miramar, FL
Develops light-based treatment technology for people with vascular diseases, including brain aneurysms.
II
InNeuroCo, Inc
CEO
2014 – 2024
SN
Stryker Neurovascular
director R&D, Surpass
2012 – 2014
SL
Surpass Medical Ltd.
COO - general manager
2008 – 2012
CN
Cordis Neurovascular
Principal engineer
1997 – 2008
WI
Walt Disney Imagineering
Ride engineer
1986 – 1991
Key Colleagues at Startups
The people Marc Litzenberg works with at each company, as listed on that company's latest Form D.
NeuroFine Corp. · Form D, Apr 8, 2026
Ajay Wakhloo
Chief Executive Officer and director
JM
John McEleney
Director
DS
Daniel Sablyak
Director
BN
Bernie Navarro
Executive officer
Deinde Medical Corp. · Form D, Nov 12, 2025
BN
Bernie Navarro
Executive officer
PL
Prattipati Laxminarain
Director
Ajay Wakhloo
Director
JM
John McEleney
Director
Prometheus Therapeutics Inc. · Form D/A, Jun 21, 2024
Ajay Wakhloo
CEO and director
Baruch Lieber
President & CSO, director
BN
Bernardo Navarro
Executive officer